ClinicalTrials.govpublic full text
Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib
multiple myeloma, relapse after use of lenalidomide and bortezomib, relapsed myeloma patients, relapsed after use of bortezomib and lenalidomide, pomalidomide and dexamethasone, efficacy and safety, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905097
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.